In a forthcoming research paper, Anne Strong Caldwell, MD, a PGY-3 ophthalmology resident at the University of Colorado School of Medicine, finds that there is no significant difference in adverse outcomes between anti-vascular endothelial growth factor (anti-VEGF) treatments and laser treatments given to babies with retinopathy of prematurity (ROP) in a real-world setting.
CU Anschutz
Rocky Mountain Lions Eye Institute
1675 North Aurora Court
F731
Aurora, CO 80045